{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:05:00Z","timestamp":1777622700108,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Monocytes play an important role in innate immunity and atherosclerosis. A disturbed secretion of cytokines in lipopolysaccharide (LPS) activated monocytes from type 1 diabetes (T1D) patients has been described and may contribute to the impaired inflammatory response in these individuals. In the present study the influence of LPS on five different proteins with a function in immunity and atherosclerosis was analyzed in monocytes from controls and T1D patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Monocytes were isolated from controls and T1D patients and the LPS-stimulated increase of IL-6, CXCL8, monocyte chemotactic protein 1 (CCL2, MCP-1) and superoxide dismutase (SOD 2), as well as the LPS-mediated decrease of apolipoprotein E (Apo E) in primary human monocytes from controls and T1D patients was determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CCL2 and IL-6 secretion in response to LPS was found significantly reduced in monocytes from T1D patients when compared to controls whereas basal CCL2 release was similar in control and T1D cells. In contrast, CXCL8 and apolipoprotein E secretion and SOD 2 expression upon LPS stimulation is similar from T1D and control monocytes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These data indicate that LPS-mediated protein expression is only partly disturbed in monocytes from T1D patients. Reduced secretion of IL-6 and CCL2 in activated monocytes of these patients may contribute to an impaired inflammatory response and vascular disease.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1475-2840-5-5","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T12:49:52Z","timestamp":1144327792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes"],"prefix":"10.1186","volume":"5","author":[{"given":"Gabriele","family":"Wehrwein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Neumeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Sch\u00e4ffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Abke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Sch\u00f6lmerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,27]]},"reference":[{"key":"57_CR1","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1172\/JCI115055","volume":"87","author":"IL Campbell","year":"1991","unstructured":"Campbell IL, Kay TW, Oxbrow L, Harrison LC: Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD\/Wehi mice. J Clin Invest. 1991, 87: 739-742.","journal-title":"J Clin Invest"},{"key":"57_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.","journal-title":"Diabet Med"},{"key":"57_CR3","first-page":"68","volume":"26","author":"T Jensen","year":"1992","unstructured":"Jensen T, Deckert T: Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients. Horm Metab Res Suppl. 1992, 26: 68-70.","journal-title":"Horm Metab Res Suppl"},{"key":"57_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2337\/diab.41.2.202","volume":"41","author":"DE Singer","year":"1992","unstructured":"Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC: Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes. 1992, 41: 202-208.","journal-title":"Diabetes"},{"key":"57_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0891-5520(05)70383-4","volume":"11","author":"JE Patterson","year":"1997","unstructured":"Patterson JE, Andriole VT: Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am. 1997, 11: 735-750. 10.1016\/S0891-5520(05)70383-4.","journal-title":"Infect Dis Clin North Am"},{"key":"57_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","volume":"26","author":"SE Geerlings","year":"1999","unstructured":"Geerlings SE, Hoepelman AI: Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999, 26: 259-265.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"57_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0008-8749(03)00043-1","volume":"221","author":"M Spatz","year":"2003","unstructured":"Spatz M, Eibl N, Hink S, Wolf HM, Fischer GF, Mayr WR, Schernthaner G, Eibl MM: Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell Immunol. 2003, 221: 15-26. 10.1016\/S0008-8749(03)00043-1.","journal-title":"Cell Immunol"},{"key":"57_CR8","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.77.4.1072","volume":"77","author":"Y Ohno","year":"1993","unstructured":"Ohno Y, Aoki N, Nishimura A: In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1993, 77: 1072-1077. 10.1210\/jc.77.4.1072.","journal-title":"J Clin Endocrinol Metab"},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1046\/j.1365-2362.2000.00745.x","volume":"30","author":"SE Geerlings","year":"2000","unstructured":"Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W, Stolk RP, Hoepelman AI: Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest. 2000, 30: 995-1001. 10.1046\/j.1365-2362.2000.00745.x.","journal-title":"Eur J Clin Invest"},{"key":"57_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2337\/diabetes.49.7.1106","volume":"49","author":"DG Alleva","year":"2000","unstructured":"Alleva DG, Pavlovich RP, Grant C, Kaser SB, Beller DI: Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes. 2000, 49: 1106-1115.","journal-title":"Diabetes"},{"key":"57_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/eji.200425513","volume":"35","author":"G Bouma","year":"2005","unstructured":"Bouma G, Nikolic T, Coppens JM, van Helden-Meeuwsen CG, Leenen PJ, Drexhage HA, Sozzani S, Versnel MA: NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation. Eur J Immunol. 2005, 35: 225-235. 10.1002\/eji.200425513.","journal-title":"Eur J Immunol"},{"key":"57_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/00365540310015926","volume":"35","author":"S Hashimoto","year":"2003","unstructured":"Hashimoto S, Morohoshi K, Suzuki T, Matsushima K: Lipopolysaccharide-inducible gene expression profile in human monocytes. Scand J Infect Dis. 2003, 35: 619-627. 10.1080\/00365540310015926.","journal-title":"Scand J Infect Dis"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2249.2005.02865.x","volume":"141","author":"G Bouma","year":"2005","unstructured":"Bouma G, Coppens JM, Lam-Tse WK, Luini W, Sintnicolaas K, Levering WH, Sozzani S, Drexhage HA, Versnel MA: An increased MRP8\/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes. Clin Exp Immunol. 2005, 141: 509-517. 10.1111\/j.1365-2249.2005.02865.x.","journal-title":"Clin Exp Immunol"},{"key":"57_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo IF, Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006, 354: 610-621. 10.1056\/NEJMra052723.","journal-title":"N Engl J Med"},{"key":"57_CR15","doi-asserted-by":"crossref","first-page":"C740","DOI":"10.1152\/ajpcell.1998.275.3.C740","volume":"275","author":"L Tian","year":"1998","unstructured":"Tian L, White JE, Lin HY, Haran VS, Sacco J, Chikkappa G, Davis FB, Davis PJ, Tsan MF: Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Am J Physiol. 1998, 275: C740-7.","journal-title":"Am J Physiol"},{"key":"57_CR16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1155\/1993\/678310","volume":"11","author":"F Pociot","year":"1993","unstructured":"Pociot F, Lorenzen T, Nerup J: A manganese superoxide dismutase (SOD2) gene polymorphism in insulin-dependent diabetes mellitus. Dis Markers. 1993, 11: 267-274.","journal-title":"Dis Markers"},{"key":"57_CR17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1189\/jlb.1004583","volume":"78","author":"M Karima","year":"2005","unstructured":"Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam BH, Malabanan A, Trackman PC, Badwey JA, Van Dyke TE: Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol. 2005, 78: 862-870. 10.1189\/jlb.1004583.","journal-title":"J Leukoc Biol"},{"key":"57_CR18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1161\/01.RES.0000187467.67684.43","volume":"97","author":"K Ali","year":"2005","unstructured":"Ali K, Middleton M, Pure E, Rader DJ: Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ Res. 2005, 97: 922-927. 10.1161\/01.RES.0000187467.67684.43.","journal-title":"Circ Res"},{"key":"57_CR19","first-page":"253","volume":"6","author":"L Larkin","year":"2000","unstructured":"Larkin L, Khachigian LM, Jessup W: Regulation of apolipoprotein E production in macrophages (review). Int J Mol Med. 2000, 6: 253-258.","journal-title":"Int J Mol Med"},{"key":"57_CR20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jlb.55.6.743","volume":"55","author":"SH Zuckerman","year":"1994","unstructured":"Zuckerman SH, O'Neal L: Endotoxin and GM-CSF-mediated down-regulation of macrophage apo E secretion is inhibited by a TNF-specific monoclonal antibody. J Leukoc Biol. 1994, 55: 743-748.","journal-title":"J Leukoc Biol"},{"key":"57_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/hc3401.093153","volume":"104","author":"HA Lehr","year":"2001","unstructured":"Lehr HA, Sagban TA, Ihling C, Zahringer U, Hungerer KD, Blumrich M, Reifenberg K, Bhakdi S: Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation. 2001, 104: 914-920.","journal-title":"Circulation"},{"key":"57_CR22","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0735-1097(99)00448-9","volume":"34","author":"CJ Wiedermann","year":"1999","unstructured":"Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, Willeit J: Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol. 1999, 34: 1975-1981. 10.1016\/S0735-1097(99)00448-9.","journal-title":"J Am Coll Cardiol"},{"key":"57_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nm1008","volume":"10","author":"H Bjorkbacka","year":"2004","unstructured":"Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW: Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004, 10: 416-421. 10.1038\/nm1008.","journal-title":"Nat Med"},{"key":"57_CR24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0022-2275(20)42043-7","volume":"32","author":"BY Ishida","year":"1991","unstructured":"Ishida BY, Blanche PJ, Nichols AV, Yashar M, Paigen B: Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL\/6 and C3H. J Lipid Res. 1991, 32: 559-568.","journal-title":"J Lipid Res"},{"key":"57_CR25","volume-title":"Atherosclerosis","author":"MB Lobbes","year":"2005","unstructured":"Lobbes MB, Lutgens E, Heeneman S, Cleutjens KB, Kooi ME, van Engelshoven JM, Daemen MJ, Nelemans PJ: Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis. 2005"},{"key":"57_CR26","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1161\/01.RES.0000146672.10582.17","volume":"95","author":"IF Charo","year":"2004","unstructured":"Charo IF, Taubman MB: Chemokines in the pathogenesis of vascular disease. Circ Res. 2004, 95: 858-866. 10.1161\/01.RES.0000146672.10582.17.","journal-title":"Circ Res"},{"key":"57_CR27","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.4049\/jimmunol.173.10.6366","volume":"173","author":"DJ Grainger","year":"2004","unstructured":"Grainger DJ, Reckless J, McKilligin E: Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol. 2004, 173: 6366-6375.","journal-title":"J Immunol"},{"key":"57_CR28","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.2174\/0929867033456477","volume":"10","author":"M Inoue","year":"2003","unstructured":"Inoue M, Sato EF, Nishikawa M, Park AM, Kira Y, Imada I, Utsumi K: Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem. 2003, 10: 2495-2505. 10.2174\/0929867033456477.","journal-title":"Curr Med Chem"},{"key":"57_CR29","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","volume":"101","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000, 101: 1767-1772.","journal-title":"Circulation"},{"key":"57_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/07853890109002058","volume":"33","author":"H Koukkunen","year":"2001","unstructured":"Koukkunen H, Penttila K, Kemppainen A, Halinen M, Penttila I, Rantanen T, Pyorala K: C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med. 2001, 33: 37-47.","journal-title":"Ann Med"},{"key":"57_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1399-543X.2005.00136.x","volume":"6","author":"RJ Liberatore Rdel","year":"2005","unstructured":"Liberatore Rdel RJ, Barbosa SF, Alkimin MG, Bellinati-Pires R, Florido MP, Isaac L, Kirschfink M, Grumach AS: Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2005, 6: 206-212. 10.1111\/j.1399-543X.2005.00136.x.","journal-title":"Pediatr Diabetes"},{"key":"57_CR32","first-page":"1229","volume":"136","author":"BJ Rollins","year":"1990","unstructured":"Rollins BJ, Yoshimura T, Leonard EJ, Pober JS: Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1\/JE. Am J Pathol. 1990, 136: 1229-1233.","journal-title":"Am J Pathol"},{"key":"57_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cyto.2004.12.006","volume":"30","author":"AM Ferreira","year":"2005","unstructured":"Ferreira AM, Rollins BJ, Faunce DE, Burns AL, Zhu X, Dipietro LA: The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation. Cytokine. 2005, 30: 64-71. 10.1016\/j.cyto.2004.12.006.","journal-title":"Cytokine"},{"key":"57_CR34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11373-005-9024-z","volume":"12","author":"GM Puddu","year":"2005","unstructured":"Puddu GM, Cravero E, Arnone G, Muscari A, Puddu P: Molecular aspects of atherogenesis: new insights and unsolved questions. J Biomed Sci. 2005, 12: 839-853. 10.1007\/s11373-005-9024-z.","journal-title":"J Biomed Sci"},{"key":"57_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/01.shk.0000144130.36771.d6","volume":"23","author":"MM Ndengele","year":"2005","unstructured":"Ndengele MM, Muscoli C, Wang ZQ, Doyle TM, Matuschak GM, Salvemini D: Superoxide potentiates NF-kappaB activation and modulates endotoxin-induced cytokine production in alveolar macrophages. Shock. 2005, 23: 186-193. 10.1097\/01.shk.0000144130.36771.d6.","journal-title":"Shock"},{"key":"57_CR36","doi-asserted-by":"crossref","first-page":"10642","DOI":"10.1016\/S0021-9258(17)44505-4","volume":"258","author":"Z Werb","year":"1983","unstructured":"Werb Z, Chin JR: Endotoxin suppresses expression of apoprotein E by mouse macrophages in vivo and in culture. A biochemical and genetic study. J Biol Chem. 1983, 258: 10642-10648.","journal-title":"J Biol Chem"},{"key":"57_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0898-6568(00)00149-2","volume":"13","author":"M Guha","year":"2001","unstructured":"Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal. 2001, 13: 85-94. 10.1016\/S0898-6568(00)00149-2.","journal-title":"Cell Signal"},{"key":"57_CR38","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.4049\/jimmunol.161.10.5681","volume":"161","author":"PA Scherle","year":"1998","unstructured":"Scherle PA, Jones EA, Favata MF, Daulerio AJ, Covington MB, Nurnberg SA, Magolda RL, Trzaskos JM: Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol. 1998, 161: 5681-5686.","journal-title":"J Immunol"},{"key":"57_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0898-6568(00)00149-2","volume":"13","author":"M Guha","year":"2001","unstructured":"Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal. 2001, 13: 85-94. 10.1016\/S0898-6568(00)00149-2.","journal-title":"Cell Signal"},{"key":"57_CR40","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.4049\/jimmunol.161.10.5681","volume":"161","author":"PA Scherle","year":"1998","unstructured":"Scherle PA, Jones EA, Favata MF, Daulerio AJ, Covington MB, Nurnberg SA, Magolda RL, Trzaskos JM: Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol. 1998, 161: 5681-5686.","journal-title":"J Immunol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-5-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T23:13:35Z","timestamp":1683414815000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-5-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,27]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-5-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,27]]},"assertion":[{"value":"19 January 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}